Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547)

Merck Sharp & Dohme (MSD)

Status: Completed

Conditions: Fungal Infections

Treatments: Drug: Posaconazole oral suspension 40 mg/mL

Study type: Observational

Funder types: Industry

Identifiers

NCT01436578

P08547

MK-5592-091 (Other Identifier)

Details and patient eligibility

About

This study will examine the safety and efficacy of posaconazole in general use in Korea.

Post-marketing surveys are not considered applicable clinical trials and thus the results of this survey will not be posted at its conclusion. The results will be submitted to public health officials as required by applicable national and international laws.

Enrollment: 273 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Treated with posaconazole oral suspension within current local label

Exclusion criteria

• Contraindication to posaconazole oral suspension according to current local label

Trial design

273 participants in 1 patient group

All Participants

Description:

All participants treated with posaconazole oral suspension during the pre-specified surveillance period.

Treatment:

Drug: Posaconazole oral suspension 40 mg/mL